RP-BP-EF003: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4 to Under 6 Years Diagnosed with ADHD
Clinical Trial Grant
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Rhodes Pharmaceuticals L.P.
Start Date
May 1, 2016
End Date
April 30, 2018
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Rhodes Pharmaceuticals L.P.
Start Date
May 1, 2016
End Date
April 30, 2018